4//SEC Filing
Mammen Mathai 4
Accession 0000899243-19-023636
CIK 0001770787other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:19 PM ET
Size
8.2 KB
Accession
0000899243-19-023636
Insider Transaction Report
Form 4
Mammen Mathai
Director
Transactions
- Other
Stock Option (right to buy)
2019-09-16−200,000→ 0 totalExercise: $1.16Exp: 2027-06-12→ Class B Common Stock (200,000 underlying) - Other
Stock Option (right to buy)
2019-09-16+200,000→ 200,000 totalExercise: $1.16Exp: 2027-06-12→ Class A Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering.
- [F2]One forty-eighth of the shares subject to the option vested on July 12, 2017 and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.
Documents
Issuer
10x Genomics, Inc.
CIK 0001770787
Entity typeother
Related Parties
1- filerCIK 0001421050
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:19 PM ET
- Size
- 8.2 KB